practolol has been researched along with Death, Sudden in 11 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a large-scale double-blind controlled trial of practolol (200 mg twice daily) in the long-term prophylactic treatment of 3038 patients recovering from acute myocardial infarction treatment was started one to four weeks after the acute attack." | 9.04 | Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. ( , 1975) |
| "In a large-scale double-blind controlled trial of practolol (200 mg twice daily) in the long-term prophylactic treatment of 3038 patients recovering from acute myocardial infarction treatment was started one to four weeks after the acute attack." | 5.04 | Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study. ( , 1975) |
| "Most of those liable to sudden death can be identified and it is possible that by the use of beta-adrenergic blocking or other antiarrhythmic drugs, by reducing the consumption of cigarettes and perhaps, by different therapies for hypertension, a substantial proportion of coronary deaths might be prevented or, at least, postponed." | 1.26 | Toward preventing coronary death from ventricular fibrillation. ( Julian, DG, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frishman, WH | 1 |
| Hjalmarson, A | 1 |
| Smith, JW | 1 |
| Pentecost, BL | 2 |
| Ross, J | 1 |
| Chamberlain, DA | 2 |
| Julian, DG | 1 |
| Green, KG | 1 |
| Fulton, RM | 1 |
| Hamer, NA | 1 |
| Oliver, MF | 1 |
| Shah, PM | 1 |
| Adelman, AG | 1 |
| Wigle, ED | 1 |
| Gobel, FL | 1 |
| Burchell, HB | 1 |
| Hardarson, T | 1 |
| Curiel, R | 1 |
| De La Calzada, C | 1 |
| Oakley, CM | 1 |
| Goodwin, JF | 1 |
| Ulvenstam, G | 1 |
| Vedin, A | 1 |
| Wilhelmsson, C | 1 |
| Aberg, A | 1 |
2 reviews available for practolol and Death, Sudden
| Article | Year |
|---|---|
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudd | 1980 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
5 trials available for practolol and Death, Sudden
| Article | Year |
|---|---|
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudd | 1980 |
Beta blocking agents: current status in the prevention of sudden coronary death.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Atenolol; Clinical Trials as Topic; Coronary D | 1982 |
Preventing the second infarct.
Topics: Adult; Animals; Clinical Trials as Topic; Death, Sudden; Dogs; Electrocardiography; Exercise Therapy | 1980 |
Beta-adrenergic blocking agents in prevention of sudden death.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Death, Sudden; Dru | 1978 |
Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Clinical Trials as Topic; Death, Sudden; Evaluation Stu | 1975 |
6 other studies available for practolol and Death, Sudden
| Article | Year |
|---|---|
Mortality after recovery from myocardial infarction.
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Death, Sudden; Heart Failure; Humans; Myocardi | 1980 |
Editorial: Beta adrenergic blockade for prophylaxis against recurrent myocardial infarction and sudden death.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Death, Sudden; Humans; Myocardial Infarction; Practol | 1976 |
Toward preventing coronary death from ventricular fibrillation.
Topics: Adult; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Humans; Hyper | 1976 |
Improvement in prognosis of myocardial infarction by long-term beta-adrenoceptor blockade.
Topics: Animals; Blood Pressure; Death, Sudden; Humans; Myocardial Infarction; Practolol; Prognosis; Recurre | 1976 |
The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Cardiomyopathies; Child; Child, Preschool; Dea | 1974 |
[Indications for long term treatment of ventricular arrhythmias].
Topics: Alprenolol; Arrhythmias, Cardiac; Death, Sudden; Digitalis Glycosides; Electrocardiography; Humans; | 1974 |